Characterisation of normal peripheral blood cells in cycle identified by monoclonal antibody Ki-67
Related Experiment Video
Updated: Aug 10, 2026

Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma
Published on: January 9, 2019
I Cordone1, E Matutes, D Catovsky
1Academic Department of Haematology and Cytogenetics, Royal Marsden Hospital, London.
Insights
This study quantifies Ki-67 positive cells in normal blood, finding that a significant portion of lymphocytes are in cell cycle. This highlights the utility of Ki-67 staining for distinguishing normal from neoplastic cells in blood disorders.
Area of Science:
- Immunology
- Cell Biology
Background:
- Ki-67 is a nuclear antigen found in proliferating cells.
- Understanding the presence and characteristics of Ki-67 positive cells in normal peripheral blood is crucial for interpreting results in disease states.
Purpose of the Study:
- To determine the number, morphology, and cell lineage of Ki-67 positive cells in peripheral blood of healthy individuals.
- To establish a baseline for Ki-67 expression in normal lymphocytes and monocytes.
Main Methods:
- Utilized single and double immunoenzymatic staining with Ki-67 monoclonal antibody.
- Employed immunoperoxidase and immunoalkaline phosphatase techniques.
- Used specific markers for B lymphocytes, T lymphocytes, and monocytes.
Main Results:
- 2.1% of mononuclear cells and 2.7% of lymphocytes were Ki-67 positive in healthy donors.
- Most Ki-67 positive cells were small lymphocytes (88%).
- 41% of Ki-67 positive cells were T lymphocytes, and 11.4% were B lymphocytes; monocytes were negative. A significant proportion of Ki-67 positive lymphocytes were not identified by standard markers.
Conclusions:
- The described methodology effectively detects nuclear and cytoplasmic antigens simultaneously.
- A notable proportion of normal blood lymphocytes are actively cycling.
- This finding suggests that Ki-67 immunophenotyping in hematologic malignancies could help differentiate normal from neoplastic cells in proliferation.
Aims:
To investigate the numbers, morphology, and lineage assignment of Ki-67 positive cells in peripheral blood from normal subjects.
Methods:
Single and double immunoenzymatic staining procedures, immunoperoxidase, and immunoalkaline phosphatase were used with Ki-67, a monoclonal antibody that recognises a nuclear antigen present in proliferating cells, with markers expressed in B and T lymphocytes and monocytes.
Results:
In the five healthy donors 2.1% (range 1.6-3.7%) cells of the blood mononuclear fraction and 2.7% (range 2.3-3.9%) lymphocytes were Ki-67 positive. Of these, 88% (range 85-90%) were small cells and 12% (range 10-15%) were medium sized. Forty one per cent of the Ki-67 positive cells were CD3 positive by double immunoenzymatic staining and corresponded to T lymphocytes, and 11.4% were mature B cells expressing kappa or lambda light chains. Monocytes detected by the anti-lysozyme antibody were consistently Ki-67 negative. Half of the Ki-67 positive lymphocytes could not be accounted for by B or T cells with the markers used. Most Ki-67 positive cells were of small size; the B lymphocytes in cycle showed abundant cytoplasm and features suggestive of lymphoplasmacytic differentiation.
Conclusions:
The methodology described is useful for the simultaneous detection of nuclear and cytoplasmic antigens. The demonstration that a proportion of normal blood lymphocytes are in cell cycle raises the issue of whether immunophenotypic analysis of Ki-67 positive cells in haemopoietic malignancies with peripheral blood disease should be carried out to define more precisely the proportion of normal and neoplastic cells in cycle.
More Related Videos
09:17A DNA/Ki67-Based Flow Cytometry Assay for Cell Cycle Analysis of Antigen-Specific CD8 T Cells in Vaccinated Mice
Published on: January 5, 2021
14:30Immunophenotyping and Cell Sorting of Human MKs from Human Primary Sources or Differentiated In Vitro from Hematopoietic Progenitors
Published on: August 7, 2021